S&P 500   4,538.43
DOW   34,580.08
QQQ   383.13
S&P 500   4,538.43
DOW   34,580.08
QQQ   383.13
S&P 500   4,538.43
DOW   34,580.08
QQQ   383.13
S&P 500   4,538.43
DOW   34,580.08
QQQ   383.13
OTCMKTS:TKPYY

Takeda Pharmaceutical Stock Forecast, Price & News

$13.49
+0.12 (+0.90%)
(As of 12/3/2021 12:00 AM ET)
Add
Compare
Today's Range
$13.40
$13.52
50-Day Range
$13.17
$17.01
52-Week Range
$15.50
$31.29
Volume
2.18 million shs
Average Volume
979,605 shs
Market Capitalization
$21.08 billion
P/E Ratio
12.11
Dividend Yield
3.44%
Beta
0.42
30 days | 90 days | 365 days | Advanced Chart
Receive TKPYY News and Ratings via Email

Sign-up to receive the latest news and ratings for Takeda Pharmaceutical and its competitors with MarketBeat's FREE daily newsletter.


Takeda Pharmaceutical logo

About Takeda Pharmaceutical

Takeda Pharmaceutical Co., Ltd. engages in the research and development, manufacture, import and export sale, and marketing of pharmaceutical drugs. It operates through the following segments: Prescription Drug, Consumer Healthcare, and Other. The Prescription Drugs segment includes the manufacture and sale of pharmaceutical products. The Consumer Healthcare segment includes the manufacture and sale of OTC drugs and quasi-drugs. The Other segment includes manufacture and sale of reagents, clinical diagnostics, and chemical products. The company was founded by Takeda Chobei on June 12, 1781 and is headquartered in Osaka, Japan.

Headlines

Takeda Pharmaceutical (OTCMKTS:TKPYY) Hits New 1-Year Low at $14.39
November 15, 2021 |  americanbankingnews.com
Why Translate Bio's Stock Is Trading Lower Today
June 25, 2020 |  feeds.benzinga.com
Takeda Pharma TOURMALINE-MM2 Phase 3 Study Meets Primary Endpoint
March 10, 2020 |  markets.businessinsider.com
See More Headlines

Industry, Sector and Symbol

Industry
Pharmaceutical preparations
Sub-Industry
N/A
Sector
Medical
Current Symbol
OTCMKTS:TKPYY
CIK
N/A
Fax
N/A
Employees
N/A
Year Founded
1781

Sales & Book Value

Annual Sales
$15.99 billion
Cash Flow
$1.79 per share
Book Value
$11.62 per share

Profitability

Net Income
$1.68 billion
Pretax Margin
N/A

Debt

Price-To-Earnings

Miscellaneous

Outstanding Shares
1,562,360,000
Free Float
N/A
Market Cap
$21.08 billion
Optionable
Not Optionable

Social Links


MarketRank

Overall MarketRank

1.35 out of 5 stars

Analyst Opinion: 0.0Community Rank: 4.7Dividend Strength: 0.8Insider Behavior: 0.0Valuation: 1.3 5 -4 -3 -2 -1 -












Takeda Pharmaceutical (OTCMKTS:TKPYY) Frequently Asked Questions

Is Takeda Pharmaceutical a good dividend stock?

Takeda Pharmaceutical pays an annual dividend of $0.58 per share and currently has a dividend yield of 3.44%.

Who are Takeda Pharmaceutical's key executives?

Takeda Pharmaceutical's management team includes the following people:
  • Christophe Weber, President, CEO & Representative Director
  • Constantine Saroukos, Chief Financial Officer & Director
  • Andrew S. Plump, Director, Research & Development President
  • Michael E. Mendelsohn, Chief Medical & Scientific Officer
  • Norimasa Takeda, Chief Accounting Officer & Corporate Controller

What is Takeda Pharmaceutical's stock symbol?

Takeda Pharmaceutical trades on the OTCMKTS under the ticker symbol "TKPYY."

How do I buy shares of Takeda Pharmaceutical?

Shares of TKPYY can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Takeda Pharmaceutical's stock price today?

One share of TKPYY stock can currently be purchased for approximately $13.49.

How much money does Takeda Pharmaceutical make?

Takeda Pharmaceutical has a market capitalization of $21.08 billion and generates $15.99 billion in revenue each year.

Does Takeda Pharmaceutical have any subsidiaries?

The following companies are subsidiares of Takeda Pharmaceutical: ARIAD Pharmaceuticals, Baxalta Manufacturing S.à r.l., IDM Pharma Inc., Intellikine, Inviragen, LigoCyte Pharmaceuticals, Meritage Pharma Inc., Millennium Pharmaceuticals, Millennium Pharmaceuticals Inc., Nihon Pharmaceutical Co. Ltd., Nycomed Pharma, PvP Biologics, Shire, Shire ViroPharma LLC, Takeda (China) Holdings Co. Ltd., Takeda AS, Takeda Austria GmbH, Takeda Bio Development Center, Takeda California Inc., Takeda Consumer Healthcare Company Limited, Takeda Development Center Americas Inc., Takeda Development Center Asia Pte. Ltd., Takeda Development Centre Europe Ltd., Takeda Distribuidora Ltda., Takeda France S.A.S., Takeda GmbH, Takeda Ireland Limited, Takeda Italia S.p.A., Takeda Pharma A/S, Takeda Pharmaceutical (China) Company Limited, Takeda Pharmaceuticals International AG, Takeda Pharmaceuticals Korea Co. Ltd., Takeda Pharmaceuticals Limited Liability Company, Takeda Pharmaceuticals U.S.A. Inc., Takeda UK Limited, Takeda Vaccines Inc., Takeda Vaccines Pte. Ltd., and TiGenix.

When was Takeda Pharmaceutical founded?

Takeda Pharmaceutical was founded in 1781.

What is Takeda Pharmaceutical's official website?

The official website for Takeda Pharmaceutical is www.takeda.com.

Where are Takeda Pharmaceutical's headquarters?

Takeda Pharmaceutical is headquartered at 1-1 Doshomachi 4-chome Chuo-ku, Osaka M0, 540-8645.

How can I contact Takeda Pharmaceutical?

Takeda Pharmaceutical's mailing address is 1-1 Doshomachi 4-chome Chuo-ku, Osaka M0, 540-8645. The company can be reached via phone at (166) 204-2111.


This page was last updated on 12/4/2021 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.